Trv Gp Iii, LLC Voyager Therapeutics, Inc. Transaction History

Trv Gp Iii, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.0 - $10.78 $13.5 Million - $24.2 Million	-2,243,642 Reduced 41.33%	3,185,291 $24.6 Million
Q3 2022 Nov 03, 2022	SELL	$5.57 - $7.47 $5.36 Million - $7.19 Million	-962,243 Reduced 15.06%	5,428,933 $32.1 Million
Q3 2018 Oct 29, 2018	SELL	$17.11 - $21.74 $25.7 Million - $32.6 Million	-1,500,000 Reduced 19.01%	6,391,176 $121 Million
Q2 2018 Aug 07, 2018	SELL	$16.76 - $23.92 $25.1 Million - $35.9 Million	-1,500,000 Reduced 15.97%	7,891,176 $154 Million
Q4 2017 Feb 13, 2018	BUY	$12.26 - $25.88 $115 Million - $243 Million	9,391,176	9,391,176 $156 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $228M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Trv Gp Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Trv Gp Iii, LLC with notifications on news.